Treatment of Ovarian Endomethrioma

Review of Sclerotherapy By Ethanol 95% On The Rate Of Treatment Of Recurrent Ovarian Endometrioma

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT201405286541N5

Enrollment

Registered

2014-08-08

Start date

2014-09-23

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

in selected patients,will done procedure(sclerotherapy) and then will follow by trans vaginal sonography and lab data every 3months. we will have no control group ..

Treatment - Surgery

in selected patients,will done procedure(sclerotherapy) and then will follow by trans vaginal sonography and lab data every 3months. we will have no control group .

Eligibility

Sex/Gender

Female

Age

20 Years to 38 Years

Inclusion criteria

Inclusion criteria: Exclusion criteria: Complete etic form? Previous cystectomy but recurrence? FSH1? Inclusion criteria: FSH>10? AMH38? lack of etic form? Patients pregnant? Patients virgin

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Increasing of pregnancy. Timepoint: 1,3 ,6 and 12 months. Method of measurement: By songraphy and lab data.	—

Secondary

Measure	Time frame
Decreasing of abdominal pain. Timepoint: 1,3,6 and 12 months. Method of measurement: By pain score table.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Morvarid Ahmad Beygi

Shiraz University of Medical Sciences

morvarid_ab@yahoo.com s.kharati@yahoo.com+98 71 1227 9715

Outcome results